Charles River Laboratories International (CRL) FY2022 results: revenue $4.0 billion, up 12.3% on the year
Charles River Laboratories International, Inc. (CRL) reported revenue of $4.0 billion for fiscal 2022, the year ended 31 December 2022, up 12.3% on the year before. Net income was $486 million, up 24.4%, and diluted earnings per share $9.48. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2023.
Revenue
$4.0 billion
+12.3% on the year
FY2015FY2022
Operating margin
16.4%
16.7% a year earlier
FY2015FY2022
Net income
$486 million
+24.4% on the year
FY2015FY2022
Diluted EPS
$9.48
+24.7% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
620
761
547
-18.6%
Capital expenditure
325
229
167
+41.9%
Free cash flow
295
532
380
-44.6%
Free cash flow margin
7.4%
15.0%
13.0%
Cash from investing
-608
-1,438
-602
Cash from financing
-42.4
673
47.2
Depreciation and amortisation
304
266
235
+14.4%
Share-based compensation
73.6
71.5
56.3
+3.0%
Buybacks
38.7
40.7
24.0
-5.1%
Diluted shares, weighted
51m
51m
51m
-0.2%
Shares outstanding at period end
51m
50m
50m
+0.9%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
2,976
2,535
2,115
+17.4%
Non-controlling interest
4.8
4.2
3.6
+15.0%
Redeemable equity
42.4
53.0
25.5
-20.0%
Debt
2,708
2,664
1,980
+1.7%
Operating lease liabilities
390
253
156
+54.1%
Finance lease liabilities
28.3
24.5
26.0
+15.4%
Other liabilities
1,454
1,491
1,186
-2.5%
Total liabilities and equity
7,603
7,024
5,491
+8.2%
Fixed assets
1,466
1,291
1,124
+13.5%
Goodwill
2,850
2,712
1,809
+5.1%
Intangible assets
955
1,061
788
-10.0%
Investments
n/a
1.1
1.0
Cash and equivalents
234
241
228
-3.0%
Receivables
752
643
618
+17.0%
Inventory
256
199
186
+28.5%
Other assets
1,090
876
737
+24.4%
Total assets
7,603
7,024
5,491
+8.2%
10-K for the year ended 31 December 2022, filed 22 February 2023: the filing.